Okamura Akihiko, Watanabe Masayuki, Imamura Yu, Hayami Masaru, Yamashita Kotaro, Kurogochi Takanori, Mine Shinji
Department of Gastroenterological Surgery, Gastroenterology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
World J Surg. 2017 Oct;41(10):2591-2597. doi: 10.1007/s00268-017-4036-1.
The impact of glycemic status on esophageal squamous cell carcinoma (ESCC) prognosis is unclear.
A total of 623 patients who underwent curative subtotal esophagectomy for ESCC were evaluated. Diabetes was defined as a prior diagnosis of diabetes under treatment or newly diagnosed diabetes based on preoperative glycosylated hemoglobin (HbA1c) levels. Poor glycemic control was defined as HbA1c ≥ 7.0%, whereas good glycemic control was defined as HbA1c < 7.0%. The impact of glycemic status on long-term survival after esophagectomy was evaluated.
Among the 623 patients, 64 (10.3%) had diabetes including 30 (4.8%) with poor glycemic control. Although diabetes did not influence patient survival, patients with poor glycemic control had worse overall and disease-specific survival compared with those with good glycemic control (P = 0.011 and 0.039, respectively). Comparing poor glycemic control with good glycemic control, the hazard ratios (HRs) for overall and disease-specific mortality were 1.91 (1.15-3.18) and 1.89 (1.02-3.49) in univariate analysis. After multivariate adjustment, poor glycemic control also had increased risk of overall and disease-specific mortality [HR 1.72 (95% CI 1.02-2.88) and 1.65 (95% CI 0.89-3.08), respectively]. Poor glycemic control did not increase the risk of overall or disease-specific mortality in patients with stages 0-II disease but significantly increased this risk in those with stages III-IV disease [HR 2.05 (1.14-3.69) and 1.95 (1.01-3.80), respectively].
Poor glycemic control is an independent risk factor for overall and disease-specific mortality after esophagectomy for advanced-stage ESCC.
血糖状态对食管鳞状细胞癌(ESCC)预后的影响尚不清楚。
对总共623例行ESCC根治性次全食管切除术的患者进行评估。糖尿病定义为既往诊断为正在接受治疗的糖尿病或根据术前糖化血红蛋白(HbA1c)水平新诊断的糖尿病。血糖控制不佳定义为HbA1c≥7.0%,而血糖控制良好定义为HbA1c<7.0%。评估血糖状态对食管切除术后长期生存的影响。
在623例患者中,64例(10.3%)患有糖尿病,其中30例(4.8%)血糖控制不佳。虽然糖尿病不影响患者生存,但血糖控制不佳的患者与血糖控制良好的患者相比,总体生存和疾病特异性生存更差(分别为P = 0.011和0.039)。在单因素分析中,将血糖控制不佳与血糖控制良好进行比较,总体和疾病特异性死亡的风险比(HR)分别为1.91(1.15 - 3.18)和1.89(1.02 - 3.49)。多因素调整后,血糖控制不佳也增加了总体和疾病特异性死亡的风险[HR分别为1.72(95%CI 1.02 - 2.88)和1.65(95%CI 0.89 - 3.08)]。血糖控制不佳在0 - II期疾病患者中未增加总体或疾病特异性死亡风险,但在III - IV期疾病患者中显著增加了此风险[HR分别为2.05(1.14 - 3.69)和1.95(1.01 - 3.80)]。
血糖控制不佳是晚期ESCC食管切除术后总体和疾病特异性死亡的独立危险因素。